Cardinal Health (CAH) Tops Q3 EPS by 12c; raises 2024 guidance, introduces 2025 outlook

Cardinal Health (NYSE: CAH) reported Q3 EPS of $2.08, $0.12 better than the analyst estimate of $1.96. Revenue for the quarter came in at $54.9 billion, versus $56.05 billion reported last year.

GUIDANCE:

Cardinal Health sees FY2024 EPS of $7.30-$7.40, versus the consensus of $7.28.
Cardinal Health sees FY2025 EPS of at least $7.50, versus the consensus of $7.87.

For earnings history and earnings-related data on Cardinal Health (CAH) click here.

You May Also Be Interested In

• Cardinal Health (CAH) PT Raised to $250 at Mizuho
• Cardinal Health (CAH) PT Raised to $275 at Barclays
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c